Ionis’ rare neurology drug approved; Pfizer inks an ADC deal
Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.
Useful takeaways from this story.
Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.
Zanvastro is now the first approved medicine for Alexander disease.
Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.
Building the complete brief
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The useful part
Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs. Zanvastro is now the first approved medicine for Alexander disease.
Details worth keeping
Zanvastro is now the first approved medicine for Alexander disease.
Keep reading in the app
Open the app view to save this story, compare related coverage, and continue from the same source.